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SSS: secondary SCC of the skinINTRODUCTION
Metastatic squamous cell carcinoma (SCC) to the
skin, also known as secondary SCC of the skin (SSS),
is a rare entity that represents advanced disease and
carries a poor prognosis.1,2 The most commonly
reported primary sources for metastatic SCC to the
skin are head and neck cancers of the larynx,
oropharynx, tongue, epiglottis, esophagus, and
nasopharynx.1-4 Of note, SSS may also be caused
by primary cancers of the lung, bladder, vulva, and
cervix.3,4 SSS originating from head and neck SCC
(HNSCC) typically metastasize regionally to the
neck, face, and scalp, while less commonly metasta-
sizing to sites below the neck.1,2 We present a case of
distant SSS of the chest in a patient with a history of 2
invasive SCCs of the oropharynx several years prior.ceous papules and nodules.CASE REPORT
A 66-year-old man hospitalized for respiratory
failure presented in 2015 with lesions on the left
upper chest that developed rapidly over 8 days.
Medical historywas significant for 2 different primary
invasive squamous cell carcinomas: floor of the
mouth (2007) and right lateral tongue (2013).
Notable risk factors included a history of alcohol
abuse and current 30-pack-year smoking history but
no history of skin cancer. In 2007, a moderately
differentiated invasive SCC of the floor of the mouth
was identified with coexisting right submandibular
lymphadenopathy. Surgical resection of the floor-of-
mouth SCC and bilateral supraomohyoid dissection
found nodal metastasis with final staging of T1, N2c,
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Case Reports 2016;2:168-70.of cisplatin chemotherapy induced complete
remission. In 2013, an invasive, moderate to poorly
differentiated SCC with perineural invasion on the
right dorsal tongue was identified with final staging
of T1, N0, M0. A partial glossectomy and 6 weeks of
adjuvant radiation induced complete remission.
Physical examination found grouped, 3-6emm,
tender, erythematous follicular-based papules on the
left upper chest (Fig 1). Examination of the head,
neck, trunk, and extremities found no evidence of
other cutaneous lesions; however, assessment for
local recurrence of oropharyngeal SCC was difficult,
as the patient was intubated. A punch biopsy found a
nodular infiltrate in the reticular dermis composed of
atypical squamous cells containing hyperchromatic2352-5126
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Fig 2. Histopathology of SSS. A, Nodular infiltrate of atypical squamous cells centered in the
reticular dermis with no connection to the overlying epidermis. B, Infiltrate composed of
atypical squamous cells containing hyperchromatic and pleomorphic nuclei with keratin pearl
formation. (A and B, Hematoxylin-eosin stain; original magnifications: A, 34; B, 310.)
Table I. Summary of relevant SSS literature
Study Cases Summary
Lookingbill
et al3
420 patients with
cutaneous metastatic
disease, 36 with SSS
Primary tumor sites of SSS include oral cavity, 44.4% (16/36); lung, 5.6% (2/36);
larynx, 16.7% (6/36); bladder, 5.6% (2/36); nasal sinus, 5.6% (2/36); cervix,
2.8% (1/36); esophagus, 2.8% (1/36); and unknown, 16.7% (6/36).
Skin lesions from oral cancer metastases were nodular in nature in 85% of cases
(17/20).
Pitman
et al1
2491 HNSCC patients,
19 (0.76%) with SSS
Primary tumor sites of SSS include oral cavity, 47.4% (9/19); oropharynx, 10.5%
(2/19); supraglottic, 5.3% (1/19); glottis, 26.3% (5/19); and hypopharynx, 10.5%
(2/19).
Sites of SSS include neck, 47.4% (9/19); face, 21.1% (4/19); chest, 10.5% (2/19);
abdomen, 5.3% (1/19); and multiple sites 15.8% (3/19).
Yoskovitch
et al2
798 HNSCC patients,
19 (2.38%) with SSS
Primary tumor sites of SSS include oral cavity, 52.6% (10/19)*; larynx, 26.3% (5/19);
oropharynx, 10.5% (2/19); hypopharynx, 5.3% (1/19); and paranasal sinus, 5.3%
(1/19).
Sites of SSS include neck, 63.2% (12/19); scalp, 15.8% (3/19); chest, 10.5% (2/19);
and multiple chest/neck sites, 5.3% (1/19).
El Khoury4 72 patients with
cutaneous metastatic
disease, 7 with SSS
Primary tumor sites of SSS include larynx, 57% (4/7); lung, 14.3% (1/7); oropharynx,
14.3% (1/7); and vulva 14.3% (1/7).
Site of SSS include neck. 28.6% (2/7); chest, 28.6% (2/7); arm, 14.3% (1/7); back,
14.3% (1/7); and pubic area,y 14.3% (1/7)
Total 81 patients with SSS Primary tumor sites of SSS include oral cavity, 35.4% (35/99)z; oropharynx, 5.1%
(5/99); larynx, 24.2% (24/99)x; lung, 3.0% (3/99); bladder, 2.0% (2/99); cervix,
1.0% (1/99); nasal sinus, 3.0% (3/99); esophagus, 1.0% (1/99); and unknown
6.1% (6/99)
Sites of SSS include neck, 53.3% (24/45); face, 8.9% (4/45); scalp, 6.7% (3/45); chest,
15.6% (7/45); upper extremity, 2.2% (1/45); multiple unspecified sites, 6.7%
(3/45); abdomen, 2.2% (1/45); back, 2.2% (1/45); and pubic area 2.2% (1/45)
*Of the 10 oral cavity cancers, 50% (5/10) derived from floor of mouth, 40% (4/10) from tongue, and 10% (1/10) from hard palate.
yRegional metastasis from vulvar cancer.
zIncludes lesions affecting the tongue.
xIncludes the supraglottic, glottis, and hypopharynx cases from the Pitman et al1 and Yoskovitch et al2 studies.
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connection to the epidermis, consistent with meta-
static SCC (Fig 2). Surgical excision was postponeduntil the patient was no longer ventilator dependent,
but unfortunately the patient died 2 weeks after the
diagnosis of respiratory failure.
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Although primary SCC of the skin is a well-known
entity, metastatic SCC to the skin from visceral and
mucocutaneous sites, otherwise known as SSS, is a
rare occurrence and portrays a poor prognosis.1 SSS
most commonly occurs in the setting of invasive
HNSCC, especially those affecting the oropharynx.3,4
Oropharyngeal SCC may be on the rise secondary to
an increased incidence of human papilloma virus,
alcohol, and tobacco-related oral cancers.2,5
Approximately 11% of HNSCCs have distant metas-
tases, with the most common sites being the lungs,
bone, liver, and skin.6-8 Probert et al6 and Papac et al8
found that HNSCC metastasized to the skin in only
14% (n = 96) and 13% (n = 52) of cases with distant
metastases, respectively, but metastases below the
neck are exceptionally rare.2,3 The papular lesions
on our patient’s left upper chest most likely
represented distant metastases from the oral cavity
given the patient’s clinical history and the marked
similarity in histology of the new lesions when
compared with the oropharyngeal SCC histology in
2007 and 2013.
Cutaneous metastasis most commonly arises from
adenocarcinomas (especially those of the breast,
lung, and colon) and have a highly variable presen-
tation.3,4 SSS most commonly presents as single or
multiple painless nodules that may be ulcerated or
inflammatory in appearance.3 Our patient presented
with a unique acneiform eruption on his chest,
which carries a wide differential diagnosis including
acne vulgaris, chloracne, folliculitis, halogenoderma,
and certain drug eruptions (cyclosporine, antiepi-
leptic drugs, and systemic corticosteroids).9 In
regional cases of SSS, metastases are often localized
to the surgical incision site of the primary tumor,
which occurred in 62.5% (n = 8) of laryngeal cancers
and 55.6% (n = 18) of oral cavity cancers cases in one
study.3 In our review of SSS in the literature, the oral
cavity was the most common primary malignancy
site, whereas the most common location of SSS was
in the head and neck (Table I). Therefore, further
workup of patients with SSS should initially be
directed at mucocutaneous sites of the head and
neck followed by the lung, bladder, vulva, and cervix
if the initial workup is negative.3,4
As mentioned previously, the prognosis of SSS is
poor. A study by Pitman et al1 found that patients
with SSS originating from the head and neck had a
90% mortality rate by a median time of 3 months,
whereas Yoskovitch et al2 found an average survivalof 7.2 months in a similar patient population.
Treatments for SSS include external beam radiation,
surgical excision, and chemotherapy.1 Because of
the poor prognosis, patients are often placed on
palliative care measures.1 However, the only
treatment with proven efficacy to prolong life and
improve quality of life is surgical excision of SSS.10CONCLUSION
Metastatic SCC to the skin most often occurs in the
setting of HNSCC and carries a poor prognosis. It
often presents as nodular lesions in the region of the
primary cancer that may become inflamed or ulcer-
ated but can have a variety of clinical presentations
including acneiform eruptions, as in our case. The
oral cavity is the most common primary malignancy
site for development of SSS, whereas the most
common location of SSS is in the head and neck.
Treatment is often palliative using radiation therapy,
chemotherapy, and surgical excision of secondary
skin lesions; however, surgical excision is the only
therapy that has shown improved survival and
quality of life.
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